Living mapping and living network meta-analysis of Covid-19 studies

There is a newer version of the record available.

Published March 15, 2021 | Version v1
Plot Open

Table of outcomes effect size and forest plots per outcome

Creators

  • 1. Cochrane France
  • 2. Université de Paris, Inserm, Cochrane France, AP-HP, France
  • 3. Institute for Evidence in Medicine, Medical Center & Faculty of Medicine, University of Freiburg, Freiburg, Germany
  • 4. Cochrane Response
  • 5. Centre for Evidence-Based Medicine Odense (CEBMO), University of Southern Denmark and Odense University Hospital, Denmark
  • 6. Epistemonikos Foundation, Chile
  • 7. Evidence Synthesis Ireland & Cochrane Ireland, National University of Ireland, Galway, Ireland
  • 8. Institute for Evidence in Medicine, Medical Center & Faculty of Medicine, University of Freiburg and Cochrane Germany, Cochrane Germany Foundation, Freiburg, Germany
  • 9. Epistemonikos Foundation, UC Evidence Center, Cochrane Chile Associated Center, Pontificia Universidad Católica de Chile, Santiago, Chile
  • 10. Department of Anesthesia, Intensive Care and Emergency, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy

Description

Table of outcomes effect size and relevant forest plots per outcome for IL-6 blocking agents (Tocilizumab/sarilumab) as compared to standard of care/placebo; including primary analysis, sensitivity and subgroup analysis.

Files

Table of outcomes effect size and forest plots per outcome.pdf

Files (11.4 MB)

Additional details

Related works

Is supplement to
10.1002/14651858.CD013881 (DOI)